NASDAQ:GNLNGreenlane Stock Price, Forecast & News

Greenlane's stock was trading at $1.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GNLN shares have increased by 128.5% and is now trading at $3.29. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Greenlane in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Greenlane.

Greenlane is scheduled to release its next quarterly earnings announcement on Monday, June 29th 2020. View our earnings forecast for Greenlane.

Greenlane Holdings (NASDAQ:GNLN) announced its quarterly earnings results on Monday, March, 30th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by $0.67. The business earned $37.24 million during the quarter, compared to analysts' expectations of $38.88 million. Greenlane had a negative return on equity of 31.76% and a negative net margin of 14.73%. View Greenlane's earnings history.

2 equities research analysts have issued 12 month target prices for Greenlane's stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Greenlane's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 21.6% from the stock's current price. View analysts' price targets for Greenlane.

News articles about GNLN stock have trended very positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Greenlane earned a daily sentiment score of 3.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutGreenlane.

Some companies that are related to Greenlane include Medifast (MED), Fresh Del Monte Produce (FDP), Universal (UVV), United Natural Foods (UNFI), Calavo Growers (CVGW), Scholastic (SCHL), John B. Sanfilippo & Son (JBSS), Schweitzer-Mauduit International (SWM), e.l.f. Beauty (ELF), Purple Innovation (PRPL), Greencore Group (GNCGY), Meredith (MDP), Matthews International (MATW), MGP Ingredients (MGPI) and Celsius (CELH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Greenlane investors own include Ovid Therapeutics (OVID), Curaleaf (CURLF), Enphase Energy (ENPH), KushCo (KSHB), Aurora Cannabis (ACB), Inovio Pharmaceuticals (INO), Roku (ROKU), Walt Disney (DIS), Trulieve Cannabis (TCNNF) and Energy Transfer LP Unit (ET).

(GNLN) raised $80 million in an initial public offering (IPO) on Thursday, April 18th 2019. The company issued 5,300,000 shares at a price of $14.00-$16.00 per share. Cowen and Company and Canaccord Genuity served as the underwriters for the IPO and Ladenburg Thalmann, Roth Capital Partners and Northland Securities were co-managers.

Greenlane trades on the NASDAQ under the ticker symbol "GNLN."

Greenlane's stock is owned by many different retail and institutional investors. Top institutional shareholders include UBS Group AG (0.72%), BlackRock Inc. (0.58%), FNY Investment Advisers LLC (0.55%), Healthcare Value Capital LLC (0.24%), AdvisorShares Investments LLC (0.20%) and State Street Corp (0.14%). Company insiders that own Greenlane stock include Aaron Locascio, Jacoby & Co Inc, Jay M Scheiner, Pura Vida Investments, Llc, Richard Taney and Sasha Kadey. View institutional ownership trends for Greenlane.

GNLN stock was sold by a variety of institutional investors in the last quarter, including Squarepoint Ops LLC, and UBS Group AG. View insider buying and selling activity for Greenlane.

GNLN stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, State Street Corp, Healthcare Value Capital LLC, BlackRock Inc., Nuveen Asset Management LLC, and AdvisorShares Investments LLC. Company insiders that have bought Greenlane stock in the last two years include Aaron Locascio, Pura Vida Investments, Llc, and Richard Taney. View insider buying and selling activity for Greenlane.

Shares of GNLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GNLN stock can currently be purchased for approximately $3.29.

Greenlane has a market capitalization of $309.10 million and generates $185.01 million in revenue each year. The company earns $-28,820,000.00 in net income (profit) each year or $0.36 on an earnings per share basis. Greenlane employs 249 workers across the globe.

The official website for Greenlane is www.gnln.com.

Greenlane's mailing address is 1095 BROKEN SOUND PARKWAY SUITE 300, BOCA RATON FL, 33487. The company can be reached via phone at 877-292-7660 or via email at [email protected]